Access to quality, affordable medicines

Investing in Africa for Africa

Latest Media Releases

Investor Updates

Cautionary Announcement

On 14 March 2023, the Board of Directors of Cipla Quality Chemical Industries Limited (the…
Hope In Every Drop Campaign Image
Press Releases

Hope In Every Drop

To address the growing blood deficit in Uganda, Cipla Quality Chemical Industries Limited (CiplaQCIL), together…
CiplaQCIL Registers Growth Amid Tough Times
Company News
CiplaQCIL Registers Growth Amid Tough Times
CiplaQCIL appoints New CEO
Company News
CiplaQCIL appoints New CEO

We make people better and we save lives.

At Cipla Quality Chemical Industries Limited (CiplaQCIL), we are not mere manufacturers of medication. What we make are memories. Memories that may not have been there to be remembered, had a life not been lived.

We are the largest pharmaceutical manufacturer in East Africa and also one of the largest in Sub-Saharan Africa (SSA), CiplaCQIL is one of the few pharmaceutical manufacturers in SSA to operate a World Health Organization (WHO) cGMP compliant facility that manufactures a range of WHO pre-qualified medicines for treating HIV/AIDS and malaria. We manufacture antiretrovirals, artemisinin-based combination therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, malaria and Hepatitis.

At CiplaQCIL, we stand by our motto that everyone should have access to lifesaving medication.


For over two decades, we stood by our motto, “None shall be denied”.


High quality and affordable treatments for people suffering from severe malaria.


We have played a significant role in the management of Hepatitis B & C with a wide range of drugs.